Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsAstraZeneca’s tablet formulation of Calquence has been approved in the European Union (EU) for the treatment of adult patients with chronic lymphocytic leukemia.
[AstraZeneca]
Home Newsletters Hematopoiesis News Calquence Tablet Formulation Approved in the EU for Patients with Chronic Lymphocytic...
